 |
Cell Point Web: cellectar, oncology imaging agents, cardiology imaging agents, stroke imaging agents, diabetes molecular imaging agents, intra-nuclear metallic therapeutics |
Cellectar moleculesCellectar molecules are designed to "find, treat and follow"™ malignancies through the delivery of radiopharmaceuticals in a novel, highly selective way. Cellectar is a radiopharmaceutical company that designs and develops products to detect, treat and monitor a wide variety of human cancers. More About Cellectar moleculesoncology imaging agentsMedical imaging technologies have undergone explosive growth over the past few decades and now play a central role in clinical oncology. But the truly transformative power of imaging in the clinical management of cancer patients lies ahead. Today, imaging is at a crossroads, with molecularly targeted imaging agents expected to broadly expand the capabilities of conventional anatomical imaging methods. Molecular imaging will allow clinicians to not only see where a tumor is located in the body, but also to visualize the expression and activity of specific molecules (e.g., proteases and protein kinases) and biological processes (e.g., apoptosis, angiogenesis, and metastasis) that influence tumor behavior and/or response to therapy. This information is expected to have a major impact on cancer detection, individualized treatment, and drug development, as well as our understanding of how cancer arises. More About oncology imaging agentscardiology imaging agentsNuclear cardiac imaging lets your physician determine the overall
strength and function of your heart, whether you have blocked
arteries or if you suffered a previous heart attack. More About cardiology imaging agentsstroke imaging agentsCardiovascular imaging agents/Techniques More About stroke imaging agentsdiabetes molecular imaging agentsmolecular imaging can be broadly defined as the in vivo characterization and measurement of biologic processes at the cellular and molecular level. In contradistinction to “classical” diagnostic imaging, it sets forth to probe the molecular abnormalities that are the basis of disease rather than to image the end effects of these molecular alterations. While the underlying biology represents a new arena for many radiologists, concomitant efforts such as development of novel agents, signal amplification strategies, and imaging technologies clearly dovetail with prior research efforts of our specialty. Radiologists will play a leading role in directing developments of this embryonic but burgeoning field. This article presents some recent developments in molecular sciences and medicine and shows how imaging can be used, at least experimentally, to assess specific molecular targets. In the future, specific imaging of such targets will allow earlier detection and characterization of disease, earlier and direct molecular assessment of treatment effects, and a more fundamental understanding of the disease process. More About diabetes molecular imaging agentsintra-nuclear metallic therapeuticsPreventive and Therapeutic Effects of Thiamine, Ascorbic Acid and
Their Combination in Lead Intoxication More About intra-nuclear metallic therapeuticsMolecular medicine is a broad field, where physical, chemical,
biological and medical techniques are used to describe molecular
structures and mechanisms, identify fundamental molecular and
genetic errors of disease, and to develop molecular interventions to
correct them. The molecular medicine perspective emphasizes cellular
and molecular phenomena and interventions rather than the previous
conceptual and observational focus on patients and their organs.[1] |
Molecular Medicine | Cell Point Web MapAddress: 7120 E. Orchard Rd., Suite 350
Centennial, Colorado 80111
|